ライフサイエンスコーパス: cell technology

1 be crucial for medical applications of stem cell technology.

2 mutation at the DMa locus via embryonic stem cell technology.

3 m the endogenous genome using embryonic stem cell technology.

4 r1) gene were generated using embryonic stem cell technology.

5 icient for both genes through embryonic stem cell technology.

6 mutation at the DMa locus via embryonic stem cell technology.

7 -deficient mice through mouse embryonic stem cell technology.

8 deficient in Smad5 using embryonic stem (ES) cell technology.

9 nalyze Smad2 mutant embryos created using ES cell technology.

10 eficient in FKBP12 using embryonic stem (ES) cell technology.

11 H beta subunit and therefore in FSH using ES cell technology.

12 homologous recombination and embryonic stem cell technology.

13 cin have been generated using embryonic stem cell technology.

14 e region were generated using embryonic stem cell technology.

15 essed with LT-alpha using baculovirus/insect cell technology.

16 ity of iPS cells is an important goal in iPS cell technology.

17 R) are at the heart of key green-energy fuel cell technology.

18 such as artificial photosynthesis and solar cell technology.

19 he I(-)/I3(-) couple in dye-sensitized solar cell technology.

20 overall efficiency and marketability of fuel cell technology.

21 commercial viability of direct methanol fuel cell technology.

22 basis for the market-leading thin-film solar-cell technology.

23 herapeutic approaches using pluripotent stem cell technology.

24 pening the door for a truly recyclable solar cell technology.

25 n be applied to any multi-dimensional single-cell technology.

26 novel mouse strains via embryonic stem (ES) cell technology.

27 rovide an alternative to hydrogen-based fuel-cell technologies.

28 s low-cost competitor to silicon based solar cell technologies.

29 heterogeneity is a major advantage of single-cell technologies.

30 e tissues profiled using a variety of single-cell technologies.

31 terogeneous data obtained using these single-cell technologies.

32 d disease models that have incorporated stem cell technologies.

33 iciencies comparable to other emerging solar cell technologies.

34 ranslational ramifications for cortical stem cell technologies.

35 ctive AAEMs could significantly advance fuel cell technologies.

36 nered increasing support for the use of fuel-cell technology, a prime example being the solid-oxide f

37 Single-cell technologies allow characterization of transcriptom

38 which can be harnessed using microbial fuel-cell technology, allowing both wastewater treatment and

39 Development of single-cell technologies and computational methods has enabled

40 der the key challenges posed by various stem cell technologies and liver pathologies for developing c

41 human PSC clinical trials by Geron, Advanced Cell Technology and the Kobe Center for Developmental Bi

42 ranslational step in the development of stem cell technology and the subject of a report in this issu

43 fluorescent-tags are desirable in basic stem cell technology and therapeutic applications of cells.

44 ssible links between ES-cell and neural stem-cell technologies, and the strategies used to isolate an

45 spinal cord injury, there is no agreement on cell technology, and claims of beneficial results lack i

46 Recent advances in stem-cell technology are now allowing the mechanisms of human

47 se oxidation is of great interest in biofuel cell technology because the enzyme are unaffected by the

48 were generated by traditional embryonic stem cell technology, but these animals contain a biased T ce

49 ion of the development of innovation in stem cell technologies by network analysis of stem cell paten

50 Our single-cell technology can broadly link genes to biofilm fine s

51 However, before fuel-cell technology can gain a significant share of the elec

52 The current polymer-exchange membrane fuel cell technology cannot directly use biomass as fuel.

53 aches for reducing the Dmin, e.g., collision cell technology (CCT) and analyte isotope selection, are

54 ning public because of the promise that stem cell technology could deliver tissue regeneration for in

55 Emerging single-cell technologies (e.g. single-cell ATAC-seq, DNase-seq

56 er intravitreal implantation of encapsulated cell technology (ECT) devices releasing ciliary neurotro

57 The advent of induced pluripotent stem cell technology enabled the conversion of adult cells in

58 The DARC (Detection of Apoptosing Retinal Cells) technology enables in vivo real-time non-invasive

59 Development of stem cell technologies for cell replacement therapy has progr

60 Advancing pluripotent stem cell technologies for modelling haematopoietic stem cell

61 ctions remains a challenge in realizing fuel cell technologies for transportation applications.

62 tential application of gene editing and stem-cell technologies for treating human disease.

63 Finally, the use of the "bubble" cell technology for creating the detector window has bee

64 the development of induced pluripotent stem cell technology for the use of patient-specific iPSCs to

65 ed a combination of induced pluripotent stem cell technology, genomics, and molecular biology in this

66 The recent advance of single-cell technologies has brought new insights into complex

67 The recent emergence of stem cell technology has the potential to open new approaches

68 Over the past 20 years, stem cell technologies have become an increasingly attractive

69 Recent breakthroughs in pluripotent stem cell technologies have enabled a new class of in vitro s

70 Advances in flow cytometry and other single-cell technologies have enabled high-dimensional, high-th

71 Stem cell technologies have facilitated the development of hu

72 High-throughput single-cell technologies have great potential to discover new c

73 Advances in single-cell technologies have highlighted the prevalence and bi

74 Recent advances in single-cell technologies have opened new avenues to characteriz

75 Recent advances in stem cell technologies have rekindled an interest in the use

76 Recent advances in biofuel cell technology have addressed these deficiencies and in

77 Advances in stem cell technology have engendered keen interest in cell-ba

78 Recent advances in stem-cell technology have improved the prognosis for tissue e

79 Advances in stem-cell technology have led to the identification of stem c

80 , fetal intervention, and hematopoietic stem cell technology have removed many of the practical, tech

81 There are real prospects of stem cell technology having a place in clinical management of

82 Single-cell technology helps not only locate cells on this land

83 reater challenges, but rapidly emerging stem cell technologies hold the promise of autologous grafts

84 recent development of progenitor and/or stem cell technologies holds promise for the treatment of cur

85 Induced pluripotent stem (iPS) cell technology holds vast promises for a cure to the he

86 , tissue engineering, aided by emerging stem cell technology, holds immense potential for the treatme

87 gest that CNTF delivered by the encapsulated cell technology implant appears to slow the progression

88 F) delivered via an intraocular encapsulated cell technology implant for the treatment of GA.

89 l received CNTF delivered by an encapsulated cell technology implant in one eye and sham surgery in t

90 attractive cell type for applications of iPS cell technology in research and therapy.

91 Review, we describe the current state of iPS cell technology, including approaches by which they are

92 The introduction of liquid microjet and flow cell technologies into XAS experiments has enabled the g

93 This provides a key entry strategy for fuel-cell technology into the current energy economy.

94 dvent of high-throughput/high-content single cell technologies is leading to an explosion in the numb

95 Herein, dye-synthesized solar cell technology is combined with lithium-ion materials t

96 One of the key objectives in fuel-cell technology is to improve and reduce Pt loading as t

97 n be incorporated by means of embryonic stem cell technology, little progress has been made toward in

98 Highly multiplexed, single-cell technologies may be critical for identifying correl

99 Stem cell technologies may require potential for retrievabili

100 This ES cell technology may achieve the objective of obtaining a

101 vances in cell-sorting techniques and single-cell technologies now make this possible, with the ident

102 Recent advances in pluripotent stem cell technology now grant access to substantial quantiti

103 New high-dimensional, single-cell technologies offer unprecedented resolution in the

104 otype, termed induced pluripotent stem (iPS) cell technology, presents an exciting potential venue to

105 The rapid emergence of stem cell technologies, primarily using 'mesenchymal stem cel

106 , but recent integration of genomic and stem cell technologies promises a route through this impasse.

107 High-throughput single-cell technologies provide an unprecedented view into cel

108 gy strategies have rapidly entered mammalian cell technology providing novel therapeutic solutions.

109 Precise rare-cell technologies require the blood to be processed imme

110 Embryonic stem cell technology revolutionized biology by providing a me

111 the full utilization of powerful new single-cell technologies such as mass cytometry.

112 High-dimensional single-cell technologies, such as mass cytometry, offer an oppo

113 s of state-of-the-art and forthcoming single-cell technologies, such as multidimensional mass cytomet

114 The ES cell technology suggests that a therapeutic cloning appr

115 Unlike most cell technologies that are sensitive to impurities, the

116 measurements and explore advances in single-cell technologies that overcome these problems by expand

117 reater understanding of the capacity of stem cell technologies, there is growing public hope that ste

118 t al. (2015) combine gene targeting and stem cell technologies to identify a significant cellular eff

119 nally, we highlight opportunities for single cell technologies to shed light on the causes and conseq

120 It is also important for fuel cell technology to achieve efficient electrode operation

121 the seasonal deficits by using automated red cell technology to collect double red blood cell units;

122 ated Ucn-deficient mice using embryonic stem cell technology to determine its role in stress-induced

123 combination of transgenic and embryonic stem cell technology to generate a mouse line in which the mu

124 n metabolism in vivo, we used embryonic stem cell technology to generate GGT-deficient (GGTm1/GGTm1)

125 d tissue injury in humans include using stem cell technology to generate human cells for screening fo

126 F's function in vivo, we used embryonic stem cell technology to generate mice lacking KGF.

127 Consortium has used induced pluripotent stem cell technology to study the effects of common genetic v

128 ategies supporting the rapid advance of stem cell technology to the clinic, the philosophies behind t

129 Advancing perovskite solar cell technologies toward their theoretical power convers

130 derlying principles and compromises of CAR T-cell technology using the CD19-targeted CAR as a paradig

131 Using embryonic stem cell technology, we have generated viable Bloom mice tha

132 Using cell culture model and cybrid cell technology, we provide evidence that mitochondrial

133 ular components, and the advent of human iPS cell technology when combined with recent advances in th

134 Accordingly, the advent of single-cell technologies will be crucial in enabling the diagno

135 In the 21st century, stem cell technology will have to compete alongside other sop